Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
NASDAQ Composite
Standard & Poors 500
My Portfolio
Neuraxis, Inc. Common Stock
(NY:
NRXS
)
4.950
+0.340 (+7.38%)
Delayed Quote
Updated: 10:58 AM EST, Nov 18, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Neuraxis, Inc. Common Stock
< Previous
1
2
Next >
EXCLUSIVE: Small MedTech Firm NeurAxis Targets $2B Market With Post-Concussion Therapy In Kids
↗
August 29, 2023
NeurAxis Inc (NYSE: NRXS) highlighted A Prospective Study on the Effect of Auricular Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients with Post-Concussion Syndrome (PCS), a...
Via
Benzinga
SoftBank-Owned Arm, Instacart File To Go Public
↗
August 27, 2023
Via
Talk Markets
NeurAxis Announces Positive University of Michigan IB-Stim™ Cost Effectiveness Study at ANMS 2023
August 15, 2023
From
NeurAxis, Inc.
Via
GlobeNewswire
Alcoholic Beverage Marketing Company LQR Debuts On Nasdaq
↗
August 13, 2023
LQR House, which provides digital marketing and branding services to the alcohol industry, went public on Thursday, raising $5 million million in its IPO. Meanwhile NeurAxis, raised $7 million in its...
Via
Talk Markets
Topics
Initial Public Offering
Goldman Small Cap Research Publishes New Research Report on NeurAxis, Inc.
August 11, 2023
Via
ACCESSWIRE
NeurAxis Highlights Current Commercial Insurance Coverage with BCBS Massachusetts, BCBS South Carolina, BCBS Nebraska, and Quartz Wisconsin
August 10, 2023
From
NeurAxis, Inc.
Via
GlobeNewswire
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.